Article 1 : Objective

Article 2 : General Provisions

Article 3 : Use of terms

Article 4 : Scope

Article 5 : Pharmaceuticals

Article 6 : Transit and Contained Use

Article 7 : Application of the Advanced Informed Agreement Procedure

Article 8 : Notification

Article 9 : Acknowledgement of receipt of notification

Article 10 : Decision Procedure

Article 11 : Procedure for Living Modified Organisms Intended for Direct Use as Food, or Feed, or for Processing

Article 12 : Review of Decisions

Article 13 : Simplified Procedure

Article 14 : Bilateral, Regional and Multilateral Agreements and Arrangements

Article 15 : Risk Assessment

Article 16 : Risk Management

Article 17 : Unintentional Transboundary Movements and Emergency Measures

Article 18 : Handlong, Transport, Packaging and Identification

Article 19 : Competent National Authorities and National Focal Points

Article 20 : Information-Sharing and the Biosafety Clearing-House

Article 21 : Confidential Information

Article 22 : Capacity-Building

Article 23 : Public Awareness and Participation

Article 24 : Non-Parties

Article 25 : Illegal Transboundary Movements

Article 26 : Socio-Economic Considerations

Article 27 : Liability and Redress

Article 28 : Financial Mechanism and Resources

Article 29 : Conference of the Parties Serving as the Meeting of the Parties

Article 30 : Subsidiary Bodies

Article 31 : Secretariat

Article 32 : Relationship with the Convention

Article 33 : Monitoring and Reporting

Article 34 : Compliance

Article 35 : Assessment and Review

Article 36 : Signature

Article 37 : Entry into Force

Article 38 : Reservations

Article 39 : Withdrawal

Article 40 : Authentic Texts

Annex I : Information Required in Notifications under Articles 8, 10 and 13

Annex II : Information Required for Living Modified Organisms Intended for Direct Use as Food or Feed, or for Processing under Article 11

Annex III : Risk Assessment under Article 15